Abstract
The invention relates to a method of cardiac imaging using hyperpolarised <13>C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.
Original language | English |
---|---|
IPC | A61K 49/ 06 A I |
Patent number | EP1824523 |
Filing date | 29/08/2007 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 18/11/2005 |
Priority number | WO2005NO00434 |
Publication status | Published - 29 Aug 2007 |
Externally published | Yes |